P&G's Prilosec goes deep on social media

Share this article:
P&G's Prilosec goes deep on social media
P&G's Prilosec goes deep on social media
Procter & Gamble is launching a social media initiative for Prilosec as part of its bid to maintain the PPI's leadership position in a crowded market.

Dubbed “Official Sponsor of Everything You Do Without Heartburn,” the contest invites consumers to post videos and stories making their case for items—such as cameras, classes or guitars—worth an average of $1,000 that will help them pursue their passions. Entrants can submit for 15 categories, including arts and crafts, sports, health and fitness and community service and volunteerism.

Visitors to the site, officialsponsor.com can register to vote for their favorites, and winners, to be determined by fan votes and a panel, will be announced in March and May. A Facebook fan page and Twitter handle provide program updates and details

Bridge Worldwide designed the site and MS&L is handling PR on the campaign.  

In November, P&G launched a smilar campaign incorporating digital, PR, advertising and retail with its Madden Most Valuable Protector's Award. Sponsored by the brand in partnership with the NFL and John Madden, the award honors the NFL's best offensive lineman—again based on fan voting and an expert panel—and will be presented at this year's Super Bowl.
Share this article:

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...